Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?

被引：2
|
作者：
Chaudhary, Varun [1 ,2 ]
机构：
[1] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[2] McMaster Univ, Dept Surg, Hamilton, ON, Canada
来源：
EYE | 2023年 / 37卷 / 04期
关键词：
GEOGRAPHIC ATROPHY; VISUAL-ACUITY; AFLIBERCEPT; RANIBIZUMAB; BEVACIZUMAB; OUTCOMES; GROWTH; EFFICACY; REGIMEN; VISION;
D O I：
10.1038/s41433-022-02221-0
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：581 / 583
页数：3
相关论文
共 50 条
  • [1] Recurrence of neovascular age-related macular degeneration after discontinuation of modified treat and extend treatment
    Lee, Junwoo
    Choi, Jaehwan
    Yu, Seung-Young
    Kim, Kiyoung
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [2] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial
    Decroos, Francis Char
    Reed, David
    Adam, Murtaza K.
    Salz, David
    Gupta, Omesh P.
    Ho, Allen C.
    Regillo, Carl D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 180 : 142 - 150
  • [3] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Abdin, Alaa Din
    Suffo, Shady
    Asi, Fatima
    Langenbucher, Achim
    Seitz, Berthold
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (08) : 1671 - 1677
  • [4] Five-year Outcome of Aflibercept Administration with "Treat and Extend" for Neovascular Age-Related Macular Degeneration
    Wada, Iori
    Oshima, Yuji
    Fukuda, Yosuke
    Shiose, Satomi
    Kano, Kumiko
    Ishikawa, Keijiro
    Nakao, Shintaro
    Kaizu, Yoshihiro
    Hasegawa, Eiichi
    Kannan, Ram
    Ishibashi, Tatsuro
    Sonoda, Koh-Hei
    CLINICAL OPHTHALMOLOGY, 2025, 19 : 835 - 845
  • [5] Two-Year Outcomes of "Treat and Extend" Intravitreal Therapy for Neovascular Age-Related Macular Degeneration
    Arnold, Jennifer J.
    Campain, Anna
    Barthelmes, Daniel
    Simpson, Judy M.
    Guymer, Robyn H.
    Hunyor, Alex P.
    McAllister, Ian L.
    Essex, Rohan W.
    Morlet, Nigel
    Gillies, Mark C.
    OPHTHALMOLOGY, 2015, 122 (06) : 1212 - 1219
  • [6] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Soliman, Mohamed Kamel
    Tuli, Nicolas
    Lee, Thomas K.
    Britton, William A.
    Tuli, Raman
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [7] TREAT-AND-EXTEND BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION The Importance of Baseline Characteristics
    Rush, Ryan B.
    Simunovic, Matthew P.
    Vandiver, Lorelei
    Aragon, Antonio V., II
    Ysasaga, Jason E.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (05): : 846 - 852
  • [8] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
  • [9] Recurrence of neovascular age-related macular degeneration after cessation of treat and extend regimen
    Hirata, Yuki
    Oishi, Akio
    Maekawa, Yuki
    Tsuiki, Eiko
    Machida, Akira
    Kurihara, Junko
    Kitaoka, Takashi
    SCIENTIFIC REPORTS, 2022, 12 (01) : 14768
  • [10] Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study
    Augsburger, Michele
    Sarra, Gian-Marco
    Imesch, Pascal
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (09) : 1889 - 1895
12345